APG Asset Management N.V. Increases Stake in Intuitive Surgical, Inc. $ISRG

APG Asset Management N.V. increased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.3% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 698,313 shares of the medical equipment provider’s stock after purchasing an additional 2,400 shares during the quarter. Intuitive Surgical accounts for 0.6% of APG Asset Management N.V.’s investment portfolio, making the stock its 25th biggest position. APG Asset Management N.V. owned 0.19% of Intuitive Surgical worth $312,307,000 as of its most recent SEC filing.

Other hedge funds have also added to or reduced their stakes in the company. Sierra Summit Advisors LLC increased its holdings in shares of Intuitive Surgical by 5.7% in the third quarter. Sierra Summit Advisors LLC now owns 24,303 shares of the medical equipment provider’s stock worth $10,869,000 after buying an additional 1,300 shares during the period. Strategies Wealth Advisors LLC grew its position in Intuitive Surgical by 8.0% during the 3rd quarter. Strategies Wealth Advisors LLC now owns 567 shares of the medical equipment provider’s stock worth $254,000 after acquiring an additional 42 shares during the last quarter. Aviso Financial Inc. increased its stake in Intuitive Surgical by 2.5% in the 3rd quarter. Aviso Financial Inc. now owns 1,894 shares of the medical equipment provider’s stock worth $847,000 after purchasing an additional 47 shares during the period. Cache Advisors LLC increased its stake in Intuitive Surgical by 7.4% in the 3rd quarter. Cache Advisors LLC now owns 727 shares of the medical equipment provider’s stock worth $325,000 after purchasing an additional 50 shares during the period. Finally, Clal Insurance Enterprises Holdings Ltd lifted its position in Intuitive Surgical by 102.9% in the third quarter. Clal Insurance Enterprises Holdings Ltd now owns 2,029 shares of the medical equipment provider’s stock valued at $907,000 after purchasing an additional 1,029 shares during the last quarter. 83.64% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other Intuitive Surgical news, VP Fredrik Widman sold 133 shares of the firm’s stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total transaction of $65,829.68. Following the completion of the transaction, the vice president owned 660 shares of the company’s stock, valued at approximately $326,673.60. This trade represents a 16.77% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, SVP Patricia L. Wadors sold 220 shares of the company’s stock in a transaction dated Friday, February 27th. The stock was sold at an average price of $499.71, for a total transaction of $109,936.20. The SEC filing for this sale provides additional information. Insiders have sold 56,409 shares of company stock valued at $30,895,377 in the last 90 days. Corporate insiders own 0.70% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on ISRG shares. BTIG Research restated a “buy” rating and issued a $616.00 target price on shares of Intuitive Surgical in a report on Friday, January 23rd. UBS Group set a $570.00 price target on shares of Intuitive Surgical and gave the stock a “neutral” rating in a report on Tuesday. Wells Fargo & Company boosted their price objective on shares of Intuitive Surgical from $600.00 to $654.00 and gave the company an “overweight” rating in a research report on Friday, December 12th. The Goldman Sachs Group reaffirmed a “buy” rating and set a $714.00 price objective on shares of Intuitive Surgical in a research note on Friday, January 9th. Finally, Piper Sandler reissued an “overweight” rating and issued a $620.00 target price (up from $610.00) on shares of Intuitive Surgical in a research note on Friday, January 23rd. Two research analysts have rated the stock with a Strong Buy rating, fifteen have given a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and an average price target of $615.86.

Intuitive Surgical Price Performance

Shares of ISRG opened at $503.51 on Friday. The company has a 50-day simple moving average of $529.83 and a two-hundred day simple moving average of $511.71. The firm has a market capitalization of $178.81 billion, a PE ratio of 63.82, a price-to-earnings-growth ratio of 3.88 and a beta of 1.65. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.27 by $0.26. The firm had revenue of $2.87 billion during the quarter, compared to analyst estimates of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The business’s revenue was up 18.8% compared to the same quarter last year. During the same quarter in the prior year, the company earned $2.21 EPS. Analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.